Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AbbVie Inc. | SVP, CMO, GLOBAL THERAPEUTICS | Common Stock, $0.01 par value | 23.3K | $4.16M | $178.99 | Feb 28, 2024 | Direct |
AbbVie Inc. | SVP, CMO, GLOBAL THERAPEUTICS | Option (Right to buy) | 13.9K | $2M | $144.54 | Feb 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABBV | AbbVie Inc. | Feb 28, 2024 | 1 | -$880K | 4 | Mar 1, 2024 | SVP, CMO, GLOBAL THERAPEUTICS |
ABBV | AbbVie Inc. | Feb 15, 2024 | 5 | $0 | 4 | Feb 20, 2024 | SVP, CMO, GLOBAL THERAPEUTICS |
ABBV | AbbVie Inc. | Dec 14, 2023 | 0 | $0 | 3 | Dec 22, 2023 | SVP, Global Therapeutics & CMO |